Second Hospital Wu Xiaoling. THE CLINICAL VALUE OF SERUM FERRITIN AND THE RATIO OF SERUM FERRITIN/TRANSFERRIN IN HEPATOCELLULAR CARCINOMA ANDCHRONIC LIVER DISEASES[J]. Journal of Chongqing Medical University, 1986,(3):164-168.
Second Hospital Wu Xiaoling. THE CLINICAL VALUE OF SERUM FERRITIN AND THE RATIO OF SERUM FERRITIN/TRANSFERRIN IN HEPATOCELLULAR CARCINOMA ANDCHRONIC LIVER DISEASES[J]. Journal of Chongqing Medical University, 1986,(3):164-168. DOI: 10.13406/j.cnki.cyxb.1986.03.006.
血清铁蛋白和铁蛋白/转铁蛋白比值诊断肝癌及慢性肝病的临床意义
摘要
本文检测38例肝细胞性肝癌和42例其他肝病患者的血清铁蛋白(SF)和转铁蛋白(TFN)
并计算SF/TFN比值。结果证实肝癌组SF增高
SF/TFN亦显著增高
且后者与失代偿性肝硬化组的重叠较少。对肝病患者
如SF/TFN≥4
应考虑恶变可能
Abstract
Serum ferritin (SF) and transferrin (TFN) level were measured in 38 patients with hepatoce-llular carcinoma (HCC) and in 42 comparable subjects with chronic live diseases
while the ratio of SF/TFN in each group was calculated respectively .Although either SF concentration
or the ratio of SF/TFN in the group of HCC was elevated
the latter was less than the former in the over- lap of the range of concentration between HCC and cirrhosis. We have confirmed that SF as a marker of HCC is useful
but the diagnostic speciality of SF is worse. More valuable parameter in the diagnosis of HCC
specially in that of AFP-negative HCC
is the ratio of SF/TFN. Decreased TFN concentration may reflect the degree of damaged liver
but it has no role in diagnosis of HCC. If SF/TFN ratio of a patient with liver disease is>4
diagnosis of the patient would be highly suspected to be HCC